The Format Is Part of the Formula: A UK Guide to CBD Oils, Capsules, Gummies, Vapes and Topicals

UK shoppers now face a crowded shelf of CBD products, but the format on the label is not a cosmetic detail. The same molecule arrives by different routes, at different speeds, with different degrees of dose control and very different real-world costs. For a buyer in 2026, the useful question is not simply how many milligrams a product contains, but what the delivery format does with those milligrams.

This guide compares the main categories sold in the UK: oils and tinctures, capsules, gummies, inhalable products and topicals. It keeps to what is reasonably established, flags where the evidence remains thin, and sets out the packaging and batch-testing checks that should sit alongside any purchase. It is general information, not medical advice; anyone using medicines, pregnant or breastfeeding, or managing a health condition should speak to a pharmacist or clinician.

Why the delivery format matters

Delivery format affects three things that shoppers often blur together: how quickly CBD appears in the body, how long the effect is perceived to last, and how precisely the user can control the dose. A dropper allows fractional adjustment; a capsule does not. A gummy is chewed and swallowed; an oil may be held under the tongue before swallowing. An inhaled product reaches the bloodstream quickly but delivers an uncertain amount per puff. A topical is intended for local use and should not be treated as a systemic dose.

Absorption is also formulation-dependent. Carrier oils, emulsifiers, flavourings and the food matrix can all influence how much CBD is available and how consistently it is absorbed. Claims that one format is universally superior should be treated with caution. The honest position is that format should match purpose, and that product quality matters as much as category.

Oils and tinctures: the measuring stick

Oils remain the reference format for many UK users because they offer flexible dosing. A typical bottle states the total CBD content and the volume, allowing the user to calculate milligrams per drop or per millilitre. That flexibility is useful for anyone who wants to start low and adjust gradually. It also demands attention: dropper markings vary, bottles need shaking if the oil separates, and storage instructions should be followed.

Onset is often described as gradual, with some users reporting effects within 15 to 60 minutes when oil is held under the tongue, and a longer wait when it is simply swallowed. Duration is commonly reported in hours rather than minutes, though individual variation is considerable. The evidence for sublingual absorption is not as robust as marketing sometimes implies, so users should avoid treating a dropper as a precise pharmaceutical instrument.

Capsules and gummies: convenience with less control

Capsules offer a fixed dose and straightforward record-keeping. That can suit people who dislike the taste of oil or who want a simple daily routine. The trade-off is inflexibility: splitting a capsule is rarely practical, and the user cannot easily fine-tune by small increments. Capsules are swallowed, so absorption tends to be slower than with a product held in the mouth, and the perceived duration may be longer.

Gummies are pleasant and portable, but they are also a food format. The chewy matrix can delay onset, sugar content may matter to some users, and dosing is fixed per sweet. A gummy that contains 10 mg is not a low dose for everyone, particularly a first-time user. Gummies also invite casual over-consumption because they look like confectionery; that is a practical safety consideration, not a reason to dismiss the format.

Vapes and inhalables: fast onset, less certainty

Inhaled CBD products are marketed for rapid onset, and users often report effects within minutes. The duration is generally shorter than with swallowed formats. The drawbacks are substantial: the dose per puff is difficult to standardise, thermal degradation can occur, and inhalation carries respiratory risks that should not be minimised. For non-smokers, starting an inhalable CBD habit is difficult to justify on harm-reduction grounds.

UK shoppers should be especially wary of vague hardware claims and unverified fill liquids. If an inhalable product is considered at all, the batch certificate and cannabinoid profile matter as much as the device. The science here is thinner than the confident packaging suggests.

Topicals: local use, not systemic dosing

Creams, balms and gels are intended for the skin. Absorption into the bloodstream is generally low, and the rationale for use is local rather than systemic. That makes cost-per-milligram comparisons with oils misleading: a topical is not simply an oil in a different container. Patch testing is sensible, and claims that a balm treats a wide range of conditions should be treated sceptically.

The cost-per-milligram test

A useful UK shopper's method is to divide the pack price by the total CBD content. A £30 bottle containing 300 mg works out at 10p per mg; a £20 pack containing 100 mg works out at 20p per mg. For gummies or capsules, divide by the number of units and then by the CBD per unit. For inhalables, the calculation is less reliable because dose per puff is uncertain. For topicals, the figure is mostly a label comparison rather than a guide to systemic exposure.

This calculation does not tell you which product is better. It tells you what you are paying for the CBD content before formulation, testing and convenience are considered. A cheaper product with no batch certificate is not a bargain.

What to check on the UK label and batch sheet

First, check whether the product is linked to the UK novel foods framework. CBD extracts are treated as novel foods, and a responsible brand should be able to explain its regulatory position and whether it appears on the Food Standards Agency's public list. Second, look for a batch-specific certificate of analysis, not a generic PDF. It should cover cannabinoid content, THC level, and contaminants such as heavy metals, pesticides and solvents where relevant.

Third, check the stated CBD content against the batch result. Fourth, look for clear serving guidance and storage instructions. Fifth, be cautious of products that make medical claims or imply guaranteed effects. Finally, check the expiry date and packaging integrity. A QR code is useful only if it leads to a real, batch-matched document.

Matching format to purpose

For a consistent daily routine, oils and capsules are the most straightforward. For flexible dosing, oils have the edge. For convenience away from home, capsules or gummies may suit, provided the fixed dose is appropriate. For local skin use, a topical is the relevant category. For inhalables, the risk profile deserves more weight than the speed of onset. In every case, start low, keep a simple record, and do not assume that a higher dose is a better dose.

The format is part of the formula. UK shoppers who compare onset, duration, dose control and cost per milligram, then verify the batch rather than the marketing, will make a more informed choice than those who buy on flavour or fashion alone.